Product NDC: | 63323-382 |
Proprietary Name: | Neostigmine Methylsulfate |
Non Proprietary Name: | NEOSTIGMINE METHYLSULFATE |
Active Ingredient(s): | 5 mg/mL & nbsp; NEOSTIGMINE METHYLSULFATE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-382 |
Labeler Name: | Fresenius Kabi USA, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20001018 |
Package NDC: | 63323-382-10 |
Package Description: | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-382-10) > 10 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 63323-382-10 |
Proprietary Name | Neostigmine Methylsulfate |
Package Description | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-382-10) > 10 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 63323-382 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | NEOSTIGMINE METHYLSULFATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20001018 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Fresenius Kabi USA, LLC |
Substance Name | NEOSTIGMINE METHYLSULFATE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes |